Financial Post
🏢 Postmedia
📍 BC
Oct 9, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
ME Therapeutics Extends Option Agreement for CD22 Nanobody Asset
Original article ↗ Paywalled source — limited preview availableListed securities named in this item
CSE: METX
Extracted from the article text.
B.I.A.S. ANALYSIS
CENTER
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
🏢 Corporate
· Postmedia
Rolling outlet bias
CENTER
avg -0.179
8,342 articles tracked all-time
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
🔍 Intelligence Feed
Cross-Watch · Gov · Parliament · Legal · Civic
📄 Related Gov Tenders
Via Gov Watch · CanadaBuys + PSPC tenders
🏛 Related Parliament Votes
Via Civic Watch · OpenParliament.ca
🏙 Related Municipal Events
Via Civic Watch · City council, bylaws & permits
We could not isolate this article's text from the source page, so no excerpt is shown.
Read the original for the story.
Read full article at Financial Post ↗
Local coverage · British Columbia
Last 14 days, matched on province.
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Cite this analysis